The proinflammatory cytokine tumor necrosis fac tor (TNF) is known to be expressed in brain ischemia; however, its cellular and temporal appearance is not fully settled. In this study, nonradioactive in situ hybridization for murine TNF mRNA was performed on brain sections from adult C57x129 mice at 6 hours, 12 hours, 24 hours, 2 days, 5 days, or 10 days (six to eight mice per group) after induction of permanent focal cerebral ischemia. Cortical infarct volumes were estimated, and TNF mRNA-expressing cells were counted within the infarct and infarct border using Cast-Grid analysis. At 12 hours, a peak of 19.2 ± 5.1 TNF mRNA-expressing cells/mm 2 was counted, contrasting two to three times lower values at 6 and 24 hours (6.4 ± 4,6 and 9,2 ± 3.4 cells/mm 2 , respectively) and <2 cells/ mm 2 at 48 hours and later stages. The TNF mRNA-expressing cells were distributed along the entire rostrocaudal axis of the The pleiotrophic cytokine tumor necrosis factor (TNF) is produced predominantly as a secreted protein and is reported to have both neurotoxic and neuroprotective ef fects in animal models of cerebral ischemia. Normal adult rats (Simmons and Willenborg, 1990) as well as rats undergoing focal cerebral ischemia (Barone et aI., Abbreviations used: AP, alkaline phosphatase; BCrp, 5-bromo-4chloroindolyl phosphate; FBS, fetal bovine serum; GAPDH, glyceral dehyde-3-phosphate dehydrogenase; GFAP, glial fibrillary acidic pro tein; MBP, myelin basic protein; MCAO, middle cerebral artery oc clusion; NBT, nitro blue tetrazolium; pMCAO, permanent middle cerebral artery occlusion; PMN, polymorphonuclear leukocyte; SSC, saline/sodium citrate; TB S, Tris-buffered saline; TNF, tumor necrosis factor.
1997) exhibit loss (or increased loss) of neurons when TNF is injected into the brain, Administration of TNF binding protein attenuates infarct volume in mice after establishment of permanent middle cerebral artery occlu sion (pMCAO) up to 1 hour after occlusion (Nawashiro et aI., 1997a) and after pMCAO in rats (Dawson et aI., 1996; Barone et aI., 1997) as well as after transient middle cerebral artery occlusion (MCAO) in both mice (Yang et aI., 1998) and rats (Lavine et aI., 1998) , In contrast, treatment with small amounts of TNF induces ischemic tolerance in mice (Nawashiro et aI., 1997b) , Surprisingly, mice deficient in TNF develop larger in farct volumes than wild-type littermates 1 day after pM CAO induction (R Gregersen et aI., unpublished data), indicating that TNF also has neuroprotective properties, This is in line with data from Bruce et aI. (1996) showing that mice deficient in the TNF p55 and p75 receptors exhibit larger infarcts than wild-type littermates at day 1 after transient MCAO, Actions of TNF appear to depend on complicated sig nal transduction pathways that are initiated by the bind ing of TNF to its p55 and p75 receptors, Both receptors are expressed in differential levels on glial and nerve cells (Bruce et al., 1996; Tchelingerian et al., 1996; Dopp et al., 1997) as well as on infiltrating leukocytes (Hart et aI., 1996) and are overexpressed in ischemic cortex after induction of pMCAO in rats (Botchkina et aI., 1997) . The p55 receptor contains cytoplasmic domains that may either induce apoptosis or induce down stream activation of nuclear factor-kappa B (Adam et al., 1995; Borset et al., 1996) . Nuclear factor-kappa B acti vation has been demonstrated to be involved in modula tion of voltage-dependent calcium channels and gluta mate receptors (Furukawa and Mattson, 1998) , which may explain the stabilizing effect of TNF on neuronal calcium metabolism (Cheng et al., 1994; Bruce et al., 1996) . Nuclear factor-kappa B activation may also be implicated in TNF-mediated induction of antioxidant en zymes in neurons (Mattson et al., 1997) . Binding of TNF to the p75 receptor may both transduce growth and cel lular activation signals as well as activate intracellular cascades, leading to cell death (Rao et aI., 1995) .
Tumor necrosis factor induces activation of vascular endothelium (Barone et aI., 1997) and adhesion molecule expression (Yang et aI., 1998) , which attract leukocytes to pass from the blood circulation into the ischemic brain. Within the brain, TNF might modulate the inflam matory processes by activation of microglia and macro phages (Colasanti et aI., 1995; Winston et al., 1995; McLeish et aI., 1998) and induction of respiratory burst in polymorphonuclear leukocytes (PMNs) (McLeish et aI., 1998; Ottonello et al., 1998) . Furthermore, TNF stimulates the production of inducible nitric oxide syn thase and nitric oxide in astrocytes (Brodie et al., 1998) as well as prostaglandin E2 and collagenase production by human mononuclear cells (Dayer et al., 1985) . Tumor necrosis factor has also been shown to increase the syn thesis of and synergize with other inflammatory cyto kines like interleukin-ll3 and interleukin-6, which are expressed in cerebral ischemia (Buttini et al., 1994; Wang et al., 1995; Saito et al., 1996) . Among these, interleukin-113 is known to contribute to ischemia induced nerve cell degeneration (Loddick and Rothwell, 1996; Stroemer and Rothwell, 1998) .
The time course of TNF mRNA and protein expres sion has been established in ischemia by a number of standard molecular approaches. In hypoxia/ischemia in perinatal rats, reverse transcription-combined polymer ase chain reaction showed a peak of TNF mRNA at 4 hours (Szaflarski et aI., 1995) ; in t-and pMCAO in adult rats, Northern blotting showed maximal TNF mRNA ex pression at 3 and 12 hours, respectively (Liu et aI., 1994; Wang et aI., 1994) ; and in a model of transient global cerebral ischemia in gerbils, elevated levels of TNF were detected at 1 and 24 hours by enzyme-linked immuno assay techniques (Saito et aI., 1996) . However, the cel lular sources of TNF in the ischemic brain still need to be J Cereb Blood Flow Metab, Va!. 20, No. I, 2000 defined. One of the few studies using in situ hybridiza tion to locate TNF mRNA in brain ischemia points to microglia/macrophages as the cellular source in focal cerebral ischemia in rats (Buttini et al., 1996) , whereas others have reported neuronal TNF mRNA expression in a model of traumatic hippocampal injury in mice (Tche lingerian et aI., 1994) . Similarly, immunohistochemical studies have suggested that TNF is localized to either ischemic neurons (Liu et aI., 1994; Tchelingerian et al., 1996) , astrocytes (Botchkina et aI., 1997; Uno et al., 1997) , brain vasculature (Botchkina et aI., 1997) , and/or microg1ia/macrophages (Liu et al., 1994; Botchkina et al., 1997; Uno et al., 1997) within the ischemic brain. This is in contrast to in vitro data pointing to activated microglia and secondarily activated astrocytes as major producers of TNF (Sawada et al., 1989; Lafortune et al., 1996) . In inflammatory brain disease like fatal murine cerebral malaria and experimental allergic encephalomy elitis, TNF mRNA and protein are also associated pri marily with microglia/macrophages and astrocytes (Renno et al., 1995; Villarroya et aI., 1996; Medana et aI., 1997) .
In the present in situ hybridization study, we demon strate by the use of enzyme-labeled oligodeoxynucleo tide probes that TNF mRNA is expressed in a time restricted manner from 6 hours and up to 2 days after surgery in cells located primarily at the edge of and within the infarct core in C57x129 mice. We also show that these TNF mRNA-expressing cells coloca1ize with Mac-I-positive microglia and macrophages and not Ly-60 (Or-I)-positive PMNs, just as they do not coexpress the astrocytic marker glial fibrillary acidic protein (OFAP). Finally, we demonstrate by Western blotting analysis of brain homogenates from C57B1I6 mice, which display the same TNF mRNA expression profile as C57x129 mice, that soluble and transmembranous TNF protein are induced in the brain after pMCAO, sug gesting that microglial/macrophage TNF mRNA is trans lated into bioactive protein. In combination, our findings support the interpretation of microglia/macrophages as the major sources of TNF in pMCAO in mice.
MATERIALS AND METHODS

Experimental animals
The study was performed using age-matched, young adult, male C57x129 mice (bred in our own facility) and age matched, young adult, male C57BIJ6 mice (Bomholtgaard AlS, Skensved, Denmark). All mice were given free access to food and water. Forty-six C57xl29 mice, divided into six experi mental groups with 6 to 8 mice per group, and 21 C57Bl/6 mice, divided into four experimental groups, were subjected to pMCAO. The groups of C57xl29 mice were killed at either 6 or 12 hours or 1, 2, 5, or 10 days after surgery. One or two mice per group showing no histological signs of infarction, indicat ing unsuccessful MCAO, were included as sham-operated con trol mice. The C57Bl/6 mice were killed at 2 hours (n = I), 12 hours (n = 7), 48 hours (n = 5), or 5 days (n = 5). All mice were housed and cared for in accordance with the protocols and guidelines approved by the Danish Animal Health Care Com mittee.
Focal ischemia
The left distal MCA was permanently occluded (Mmer et aI., 1995) under Hypnorm (fentanyl citrate 1.3 f.Lg/1O g and fluani sone 40 f.Lg/lO g subcutaneously; Janssen-Cilag, Denmark) and
diazepam (20 f.Lg/lO g subcutaneously; Dumex, Denmark) an esthesia. The mice were placed on an operating table at 37.SOC under a dissecting microscope, and an incision was made be tween the left lateral part of the orbi t and the left ear. The parotid gland and the temporal muscle were pushed in the distal direction with a pair of anatomical forceps. A small craniotomy was made with a 0.8-mm burr above the anterior distal branch of the MCA using a high-speed microdrill. The inner layer of the skull was removed with fine forceps, and the dura and arachnoid were carefully opened. The MCA was bipolarJy elec trocauterized, applying forceps coupled to an electrosurgical unit (ICC50; Erbe, Germany). The muscle and soft tissue were replaced, and the skin was closed using 4-0 nylon suture. One milliliter of physiological 0.9% NaCI was given subcutane ously. The duration of anesthesia was 6 to 8 hours. Mice were kept for 20 hours in a recovery room at 28°C before they were transferred to the normal animal facility unit.
Decapitation
For histological processing, mice were decapitated after cer vical dislocation, and brains were rapidly removed, frozen in CO2 snow, and stored at -80°C until sectioning.
Histological processing
The brains of C57xl29 mice were cut into serial 16 f.Lm (three to four mice per group) or 30 f.Lm (four to five mice per group) coronal cryostat sections, and the brains of C57Bl/6 mice were cut into 30 f.Lm serial slices (two mice per group).
Parallel sections were Nissl stained; in situ hybridized for mu rine TNF mRNA, the "housekeeping" enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, or myelin basic protein (MBP) mRNA; or reacted immunohistochemically for the microglial/macrophage Mac-J antigen (Perry et aI., 1985) , the PMN Ly-6G (Gr-1) antigen (Fleming et aI., 1993) , or the isotype control (IgG2b) antibody for both the Mac-I and the PMN stain. A number of sections were also subjected to com bined in situ hybridization for TNF mRNA and immunohisto chemistry for the astroglial marker GFAP (Bignami and Dahl, 1985) .
In situ hybridization
Probes. Tumor necrosis factor mRNA was detected with a cocktail of two 28-mer alkaline phosphatase (AP)-Iabeled A / oligo-DNA probes based on primer sequences for reverse tran scription polymerase chain reaction detection of TNF message (Neumann et aI., 1997) [probe I: 5' -CTI CTC ATC CCT TIG GGG ACC GAT CAC C; probe II: 5'-C GTA GTC GGG GCA GCC TTG TCC CTI GAA; positions 305 to 332 and 570 to 597 of murine TNF cDNA, respectively (Pennica et aI., 1985) ].
The probes were used as a cocktail with 4 pmol of each probe/ mL. Parallel sections were hybridized with a probe specific for the mRNA encoding GAPDH [5'-XCC TGC TIC ACC ACC TIC TIG ATG ATG TCA; positions 833 to 859; 5 pmollmL (Tokunaga et aI., 1987) ] or for MBP mRNA [5'-XCT TCT GGG GCA GGG AGC CAT AAT GGG TAG T; complemen tary to bases 56 to 85 of murine MBP cDNA; 10 pmollL (Takahashi et al. 1985) ]. All AP-Iabeled probes along with their unlabeled control probes were purchased from DNA Technol ogy (Aarhus, Denmark).
Hybridization procedure. The in situ hybridization proto col has been described in detail previously (Finsen et aI., 1992) .
In brief, the sections were air dried and fixed in 96% ethanol at Control reactions. Probe specificity was tested by hybrid izing parallel sections with probe I, probe II, or the cocktail containing both probes. As expected, this resulted in identical regional and cell type-specific location of the hybridization signal and a stronger hybridization signal in sections hybridized with the probe cocktail than with probe I or II alone (not shown). The specificity of the hybridization reaction was tested by pretreatment of the sections with RNase A (50 f.Lg/mL; 27-0323-01; Pharmacia LKB Biotechnology, Sweden) in 10 mmollL Tris-HCI, 0.5 mollL NaCI, and 1 mmollL ethylenedi aminetetraacetate (pH 8.0) prior to hybridization, hybridization B of sections with a 100-fold excess of unlabeled TNF probe 1 and II, hybridization with hybridization buffer alone, or hybrid ization of sections with a probe with the same CG ratio as the TNF probes but directed against oligodendrocyte MBP mRNA.
The first three hybridization controls were blank (Fig. 1) . The Combined in situ hybridization and immunohistochem istry. In situ hybridization for TNF mRNA was combined with immunostaining for GFAP on 16-and 30-fLm-thick brain slices from mice with 6-, 12-, and 24-hour survival. The protocol of Trembleau et al. (1993) Sections were washed three times in Tris-Mg 2+ buffer for 10 minutes and in TBS (pH 7.5) for 10 minutes at room tempera ture. Peroxidase development was performed using 0.025% di amino benzidine and 0.006% H 2 0 2 diluted in 0.05 mollL TBS (pH 7.4). Sections were washed in TBS (pH 7.4) for 10 minutes followed by 2 x 10 minute washes in Tris-Mg 2+ buffer and 2 x 10 minute washes in Tris-HCI (pH 9.5) at room temperature.
Alkaline phosphatase development of the hybridization signal was done in the NBTIBCIP developing solution as described previously, and sections were mounted in AquaMount.
Infarct volume estimation
Infarct areas or total infarct volumes were estimated on 30-fLm Nissl-stained sections using the computer-assisted cast-grid microscope system (Olympus, Denmark) and Cavalieri prin ciple for volume estimation (Moller et aI., 1995; West et aI., 1996) . The number of points hitting the infarct (P) were counted on sections with a mean distance (t) of 0.36 mm. The sum of the infarct areas of different brain slices was calculated by mUltiplying the total number of counted points C 2. P) with the computer-given factor of area per point (Apoin,)' The total in farct volume (V'o'al) was calculated using the following for mula: V,o,al = "i. P x Apoint X t. Volume estimation of the hemispheres or of the whole brain (without the cerebellum) was performed similarly to infarct volume assessment.
Density of TNF mRNA-expressing cells
Cells displaying a moderate to strong TNF mRNA hybrid ization signal in the infarct and bordering area were visualized by 500x amplification in the cast-grid microscope system. All F.
Statistical analysis
Group mean ± SD of infarct volumes or cell density were compared by unpaired Student's t-test. Statistical significance was set at P < 0.05.
Western blotting for TNF
C57Bl!6 mice were given an overdose of pentobarbital 
RESULTS
Infarct development
The pMCAO caused unilateral cortical infarction within the parietal and insular cortices. The infarcts dis played characteristic Nissl-stainable shrunken neurons with hyperchromatic nuclei (not shown). Mean infarct yolumes remained constant from 6 hours and up to 5 days after surgery (Fig. 2) and were -25 mm 3 or occu pied -8% of the total brain (minus cerebellum) volume. Infarct volumes at day 10 were significantly smaller due to resorption of the infarcted tissue (Fig. 2) .
Regional and temporal localization of TNF
mRNA-expressing cells
At 6 and 12 hours and 1 day after pMCAO, moderate to high levels of TNF mRNA were expressed in process bearing microglia/macrophage-like cells located in vari able densities at the margin of the infarcted areas and within the infarct core (Figs. 3 to 5 Group means ± SD were as follows: 6 hours (6.4 ± 4.6/mm2; n = 3), 12 hours (19.2 ± 5.1/mm2; n = 4), 24 hours (9.2 ± 3. 4/mm2; n = 4), 48 hours (1.3 ± 0.2 /mm2; n = 2), 5 days (0.3 ± 0.2/mm2; n = 5), and 10 days (0.0 ± 0.0/mm2; n = 6), revealing highest densities at 12 hours. minimal TNF mRNA signal (Fig. 3) . Cast-grid analysis of the temporal density of TNF mRNA-positive cells in the infarct and at the infarct border showed peak density at 12 hours, with markedly lower density at 6 and 24 hours (Fig. 4) . Strongly GFAP-immunoreactive astro cytes were present at the boundary of the infarct and in the corpus callosum and capsula externa (Fig. 5) . TNF in situ hybridization combined with immunohistochemistry for astroglial GFAP gave no evidence of TNF mRNA expression by GFAP-immunoreactive astrocytes (Fig. 5 ).
Mac-! stain
At all time points, pMCAO-induced infarcts were de marcated by up-regulated levels of Mac-I ( Figs. 6 and  7) . At 6 hours, microglial cells at the edge of the infarct were lightly activated, showing up-regulated levels of Mac-l and slightly retracted processes. This microglial reaction had further increased at 12 hours, at which time typical microglial profiles no longer were visible within the core of the infarct. Also, at 12 hours and especially at 24 hours, infiltrating round Mac-I-positive macrophages appeared adjacent to vascular endothelium or meningeal tissue. These cells were distributed within cortical layers 1 to 3 at 12 to 24 hours, layers 3 to 4 at 48 hours, and cortical layers 4 to 6 of the infarct core (Fig. 6) . "B ushy" like microglia/macrophages were observed within the corpus callosum in both hemispheres and in the contra lateral neocortex at days 5 and 10. At day 10, the par tially resorbed infarct still contained intensely labeled Mac-I-positive macrophages (Fig. 7) .
Polymorphonuclear leukocytes
From 24 to 48 hours after the onset of ischemia, PMNs extravasated from blood vessels located in the border zone of the infarct and in the corpus callosum (Fig. 8D) . Whereas no PMNs were present at day 5, these cells reappeared at day 10, when they were abundant within and at the edge of the necrotic infarct and in the corpus callosum.
TNF protein
Murine TNF soluble protein (19-kDa band) and the TNF transmembranous form (22-kDa band) were de tected in homogenates of ipsilateral neocortex of C57BlI6 mice at 2 hours, 12 hours, 48 hours, and 5 days after pMCAO surgery ( Fig. 9 ) and in the contralatereal neocortex at 12 hours (Fig. 9 ). Furthermore, 14-kDa bands appeared, which were taken to represent degrada tion products of TNF. One control mouse (with craniot omy but no artery occlusion) showed almost undetect able TNF levels [or 14-, 19-, and 22-kDa bands] at 12 hours (Fig. 9) . The "positive" control, murine recombi nant TNF, gave in all cases a strong band at 17 kDa.
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DISCUSSION
In the present study, we report on an early postsurgery induction of TNF protein in a murine model for focal cerebral ischemia. To determine the cellular origin of such TNF production in ischemia-induced neuropathol ogy, a sensitive and reliable nonradioactive in situ hy bridization method was established for visualization of TNF mRNA in brain tissue. This method revealed a dis tinct cellular TNF mRNA in situ hybridization signal within the infarct core and at the edge of the infarct from 6 to 48 hours after induction of pMCAO in C57xI29 (8), 24 hours (c), 2 days (0), 5 days (E), and 10 days (F) after the onset of ischemia (shown at the level of septum or ros tral hippocampus). Round Mac-1positive macrophages progressively infiltrate the infarct core (IF), showing highest densities from 48 hours (see also Fig. 9 ). Microgliaimacrophages in corpus callosum (cc) and in striatal white matter (STR) show increased levels of Mac-1 at all postischemic time points and maximal levels at days 5 and 10. Original magnification, x16. Arrows indicate the IF border shown at high power in Fig. 7. mice, with peak density of TNF mRNA-expressing cells at 12 hours. Importantly, neither astrocytes nor neurons were shown to express TNF mRNA. This was surprising as TNF protein has been reported to be produced by neurons in focal cerebral ischemia (Liu et aI., 1994) and TNF mRNA to be expressed in neurons in adult mouse brain after traumatic hippocampal injury (Tchelingerian et aI., 1996) . The striking lack of PMNs at time points with high TNF mRNA expression and the absence of colocalization between PMNs and cellular TNF mRNA expression document that PMNs were not responsible for the observed TNF mRNA expression. In contrast, TNF mRNA expression colocalized with Mac-I-positive mi- A c croglia/macrophages, thereby pointing to activated mi croglia and infiltrating blood-borne macrophages as the major sources of TNF from 6 to 48 hours after induction of pMCAO in mice. Estimated from the morphological characteristics, these Mac-I-positive cells were most probably infiltrating blood-borne macrophages within the infarct and activated microglial cells or a mixture of activated microglia and blood-borne macrophages at the infarct border. The early expression of TNF mRNA cor responds well with the impression of microglial macrophages to be robust and potent responder cells in the early stages of the pathological process after brain IF cc E PMN ting analysis observed an almost identical temporal TNF mRNA expression profile in pMCAO in rats (Liu et aI., 1994) , except that TNF mRNA levels in that study were still significantly elevated in the ischemic cortex at day 5, Another explanation for the observation of TNF protein at day 5, when virtually no TNF mRNA-expressing cells can be observed, is that the transmembranous form of TNF may be present in microglia/macrophages and may continue to be cleaved from the membrane after down regulation of TNF gene transcription. Importantly, from a functional point of view, the expression of TNF mRNA seems to follow the temporal profile of microglial/ (22 kDa), and a degeneration product of TNF (14 kDa) are present in the ipsilateral neocortex at 2 hours, 12 hours, 48 hours, and 5 days after in duction of pMCAO in significantly higher levels than in the ipsilateral neocortex of the sham-operated mouse (12 h, ctr). These bands can also be identified in the contralateral neocortex at 12 hours (12 h, contra). C57BI/6 mice express a TNF mRNA expression profile similar to that of C57x129 mice with the presence of large numbers of TNF mRNA expressing cells (arrows) within the infarct at 12 hours after induction of pMCAO (8 and C). Original magnifi cation x6D (8); x374 (C, enlargement of 8). macrophage-derived interleukin-1[3 mRNA, which in rat pMCAO also peaks at 12 hours (Liu et ai., 1993; Yang et aI., 1998) , thus opening the possibility of a synergistic effect of microglia/macrophage-produced TNF and in terleukin-l[3 in the ischemia-induced pathology.
I
To our knowledge, this is the first study to describe the cellular localization of TNF mRNA in permanent focal cerebral ischemia in mice. Our presentation of equal in farct volumes from 6 hours and up to 5 days after the arterial occlusion points to the evolution of infarction within the first hours after the onset of permanent isch emia. This, taken together with the apparent role of TNF in ischemic neurodegeneration (Bruce et aI., 1996; Daw son et aI., 1996; Barone et aI., 1997; Nawashiro et aI., 1997a; Lavine et aI., 1998; Yang et aI., 1998) and the findings of elevated levels of TNF mRNA and protein very early after surgery in several ischemia models (Liu et aI., 1994; Wang et aI., 1994; Szaflarski et aI., 1995; Saito et aI., 1996; Buttini et aI., 1996; Botchkina et aI., 1997; Uno et aI., 1997; present study) , emphasizes the need for a further characterization of the cellular TNF --\ .
.
I I c mRNA expression within the first few hours after pM CAO.
CONCLUSION
We conclude that microglia and macrophages are ma jor sources of TNF after pMCAO in mice. This obser vation points to a pivotal function of these cells in TNF mediated neurotoxic and neuroprotective effects in cere bral ischemia.
